• Something wrong with this record ?

Pretreatment with propofol restores intestinal epithelial cells integrity disrupted by mast cell degranulation in vitro

J. Li, J. Huang, R. Zhang, Y. Lin, Q. Chen, X. Gan

. 2022 ; 71 (6) : 849-858. [pub] 20221013

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22029574

Propofol has been shown to against intestinal reperfusion injury when treated either before or after ischemia, during which mast cell could be activated. The aim of this study was to evaluate the role of propofol in restoring the intestinal epithelial cells integrity disrupted by mast cell activation or the released tryptase after activation in vitro. We investigated the effect of: (1) tryptase on Caco-2 monolayers in the presence of PAR-2 inhibitor or propofol, (2) mast cell degranulation in a Caco-2/LAD-2 co-culture model in the presence of propofol, and (3) propofol on mast cell degranulation. Epithelial integrity was detected using transepithelial resistance (TER) and permeability to fluorescein isothiocyanate (FITC)-dextran (the apparent permeability coefficient, Papp). The expression of junctional proteins zonula occludens-1 (ZO-1/TJP1) and occludin were determined using western blot analysis and immunofluorescence microscopy. The intracellular levels of reactive oxidative species (ROS) and Ca2+ were measured using flow cytometry. Tryptase directly enhanced intestinal barrier permeability as demonstrated by significant reductions in TER, ZO-1, and occludin protein expression and concomitant increases in Papp. The intestinal barrier integrity was restored by PAR-2 inhibitor but not by propofol. Meanwhile, mast cell degranulation resulted in epithelial integrity disruption in the Caco-2/LAD-2 co-culture model, which was dramatically attenuated by propofol. Mast cell degranulation caused significant increases in intracellular ROS and Ca(2+) levels, which were blocked by propofol and NAC. Propofol pretreatment can inhibit mast cell activation via ROS/Ca(2+) and restore the intestinal barrier integrity induced by mast cell activation, instead of by tryptase.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22029574
003      
CZ-PrNML
005      
20230522085507.0
007      
ta
008      
230113s2022 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934933 $2 doi
035    __
$a (PubMed)36281724
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Li, Jinfei $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China $u Department of Anesthesiology, Guangdong Women and Children Hospital, China
245    10
$a Pretreatment with propofol restores intestinal epithelial cells integrity disrupted by mast cell degranulation in vitro / $c J. Li, J. Huang, R. Zhang, Y. Lin, Q. Chen, X. Gan
520    9_
$a Propofol has been shown to against intestinal reperfusion injury when treated either before or after ischemia, during which mast cell could be activated. The aim of this study was to evaluate the role of propofol in restoring the intestinal epithelial cells integrity disrupted by mast cell activation or the released tryptase after activation in vitro. We investigated the effect of: (1) tryptase on Caco-2 monolayers in the presence of PAR-2 inhibitor or propofol, (2) mast cell degranulation in a Caco-2/LAD-2 co-culture model in the presence of propofol, and (3) propofol on mast cell degranulation. Epithelial integrity was detected using transepithelial resistance (TER) and permeability to fluorescein isothiocyanate (FITC)-dextran (the apparent permeability coefficient, Papp). The expression of junctional proteins zonula occludens-1 (ZO-1/TJP1) and occludin were determined using western blot analysis and immunofluorescence microscopy. The intracellular levels of reactive oxidative species (ROS) and Ca2+ were measured using flow cytometry. Tryptase directly enhanced intestinal barrier permeability as demonstrated by significant reductions in TER, ZO-1, and occludin protein expression and concomitant increases in Papp. The intestinal barrier integrity was restored by PAR-2 inhibitor but not by propofol. Meanwhile, mast cell degranulation resulted in epithelial integrity disruption in the Caco-2/LAD-2 co-culture model, which was dramatically attenuated by propofol. Mast cell degranulation caused significant increases in intracellular ROS and Ca(2+) levels, which were blocked by propofol and NAC. Propofol pretreatment can inhibit mast cell activation via ROS/Ca(2+) and restore the intestinal barrier integrity induced by mast cell activation, instead of by tryptase.
650    _2
$a lidé $7 D006801
650    _2
$a Caco-2 buňky $7 D018938
650    _2
$a degranulace buněk $7 D015550
650    _2
$a epitelové buňky $x metabolismus $7 D004847
650    _2
$a střevní sliznice $x metabolismus $7 D007413
650    _2
$a mastocyty $x metabolismus $7 D008407
650    _2
$a okludin $x metabolismus $7 D062793
650    _2
$a permeabilita $7 D010539
650    12
$a propofol $x farmakologie $7 D015742
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a tryptasy $x metabolismus $x farmakologie $7 D053802
655    _2
$a časopisecké články $7 D016428
700    1_
$a Huang, Jingxia $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China
700    1_
$a Zhang, Rui $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China
700    1_
$a Lin, Yiquan $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China
700    1_
$a Chen, Qianru $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China
700    1_
$a Gan, Xiaoliang $u Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 6 (2022), s. 849-858
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36281724 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230113 $b ABA008
991    __
$a 20230522085505 $b ABA008
999    __
$a ok $b bmc $g 1894769 $s 1180899
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 71 $c 6 $d 849-858 $e 20221013 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230113

Find record

Citation metrics

Archiving options